Jaguar Animal Health (JAGX)
(Delayed Data from NSDQ)
$0.18 USD
+0.01 (5.88%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.18 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Balance Sheet
Fiscal Year End for Jaguar Animal Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 6 | 5 | 17 | 8 | 4 |
Receivables | 2 | 2 | 2 | 5 | 2 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 9 | 7 | 5 | 3 | 2 |
Other Current Assets | 10 | 7 | 4 | 2 | 1 |
Total Current Assets | 28 | 22 | 28 | 18 | 10 |
Net Property & Equipment | 1 | 1 | 1 | 1 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 20 | 22 | 23 | 24 | 26 |
Deposits & Other Assets | 1 | 1 | 0 | 0 | 0 |
Total Assets | 51 | 47 | 53 | 43 | 36 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 5 | 16 | 3 | 4 | 7 |
Accounts Payable | 5 | 6 | 5 | 5 | 5 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 4 | 8 | 7 | 4 | 3 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 14 | 30 | 15 | 13 | 15 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 31 | 18 | 25 | 12 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 46 | 49 | 41 | 26 | 16 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 12 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 314 | 267 | 231 | 184 | 142 |
Retained Earnings | -308 | -267 | -219 | -167 | -133 |
Other Equity | -1 | -1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 5 | -1 | 12 | 17 | 21 |
Total Liabilities & Shareholder's Equity | 51 | 47 | 53 | 43 | 36 |
Total Common Equity | 5 | -1 | 12 | 17 | 9 |
Shares Outstanding | 73.40 | 4.30 | 0.60 | 0.50 | 0.20 |
Book Value Per Share | 0.07 | -0.32 | 19.75 | 34.40 | 44.80 |
Fiscal Year End for Jaguar Animal Health, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 6 | 3 | 9 | 14 |
Receivables | NA | 2 | 2 | 2 | 1 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 9 | 8 | 8 | 9 |
Other Current Assets | NA | 10 | 9 | 10 | 8 |
Total Current Assets | NA | 28 | 22 | 28 | 32 |
Net Property & Equipment | NA | 1 | 1 | 1 | 1 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 20 | 21 | 21 | 22 |
Deposits & Other Assets | NA | 1 | 1 | 1 | 1 |
Total Assets | NA | 51 | 45 | 52 | 57 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 5 | 4 | 14 | 16 |
Accounts Payable | NA | 5 | 5 | 5 | 6 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 4 | 3 | 10 | 9 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 14 | 12 | 29 | 31 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 31 | 31 | 17 | 18 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 46 | 44 | 46 | 49 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 314 | 301 | 298 | 287 |
Retained Earnings | NA | -308 | -299 | -291 | -279 |
Other Equity | NA | -1 | -1 | -1 | -1 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 5 | 1 | 6 | 8 |
Total Liabilities & Shareholder's Equity | NA | 51 | 45 | 52 | 57 |
Total Common Equity | 0 | 5 | 1 | 6 | 8 |
Shares Outstanding | 276.20 | 73.40 | 24.80 | 19.10 | 16.30 |
Book Value Per Share | 0.00 | 0.07 | 0.06 | 0.31 | 0.47 |